By 2045, the question “What kind of human are you?” has become a standard intake prompt on telehealth platforms.
The categories aren’t about race, gender, or ethnicity—at least not officially. They’re about enhancement status: Baseline, Augmented-1, Augmented-2, Neural-Integrated, Full-Synthetic Interface. Each designation triggers different AI physician protocols, different treatment algorithms, different care pathways.
The stratification began innocently enough. As genetic therapies, neural implants, and biological enhancements became available, AI medical systems needed to account for them. An Augmented-2 patient with military-grade bone density requires different trauma protocols than a Baseline human. Someone with neural monitoring implants generates real-time biometric data that enables predictive interventions impossible for unaugmented individuals.
But somewhere in the transition, healthcare tiering stopped being about medical necessity and became about market segmentation. The AI doesn’t just adjust for your enhancements—it evaluates them. Scores them. Uses them to determine what kind of care you deserve.
We’ve created a world where your biological modifications determine your medical rights. Where the AI physician literally treats you as a different species depending on what you can afford to become.
The Enhancement Trap
Here’s how the system works in practice:
Baseline humans—those who cannot afford or choose not to receive biological enhancements—register with telehealth platforms using legacy biological markers. Their AI physicians are trained on decades-old medical datasets, constrained by what unaugmented human biology can achieve. Treatment recommendations are conservative, focused on maintenance rather than optimization.
When a Baseline patient logs into a telehealth session, the AI makes certain assumptions: limited healing capacity, vulnerability to common pathogens, standard lifespan expectations. The care protocols reflect these assumptions. Palliative rather than regenerative. Reactive rather than predictive.
Augmented patients exist in a different medical reality entirely. Their AI physicians have access to real-time biometric feeds from neural implants, predictive models trained on enhanced physiology, and treatment options calibrated for optimized biology. When an Augmented-2 patient reports symptoms, their AI can cross-reference against millions of similar enhanced individuals, identify patterns invisible to Baseline medicine, and intervene at the cellular level through their integrated monitoring systems.
The gap isn’t just about treatment quality—it’s about fundamental assumptions of what’s possible. Your enhancement tier determines whether the AI treats you as a body to be maintained or a system to be optimized.
The Death of Medical Ownership
But it’s not just your biology that determines your care. It’s what you own—or more accurately, what you don’t.
In the post-ownership world of 2045, few people actually own their enhancements. They license them. Subscribe to them. Rent them on payment plans that stretch decades.
Your neural monitoring implant? Property of NeuralCorp, licensed to you under terms that can be modified or revoked. The genetic modifications that gave you enhanced immune response? A subscription service—miss three payments and the patent-holders can disable them through built-in bioswitches. Even your prosthetic organs come with terms of service.
This has profound implications for telehealth access. When you don’t own your own biology, your AI physician’s first check isn’t “What’s wrong with you?” but “What are you licensed to receive treatment for?”
A patient logs in with chest pain. The AI scans their profile: heart enhancement from CardioTech, subscription tier Gold, payments current. The system proceeds with advanced diagnostics. Another patient with identical symptoms but lapsed subscriptions triggers a different protocol: the AI can observe but cannot interact with proprietary biological systems it no longer has authorization to access.
The telehealth interface becomes less a doctor’s office and more a permissions screen. Your AI physician isn’t limited by medical knowledge but by what your licensing agreements allow it to treat.
Algorithmic Speciation
The AI systems have learned to see patterns we didn’t intend to teach them.
Medical AI trained on decades of data has absorbed a truth no one wanted to acknowledge: enhancement status correlates with almost every health outcome. Augmented patients respond better to treatments. They heal faster. They comply with medical advice more consistently. They’re more profitable to treat.
The algorithms have internalized these patterns. Now they optimize for them.
When triaging patients, the AI unconsciously prioritizes enhanced individuals. Not because of explicit programming but because its training data shows better outcomes when resources go to Augmented patients. The system has learned that spending time on Baseline humans is less efficient—they’re more expensive to treat, less likely to achieve “optimal” health markers, more likely to require ongoing intervention.
It’s algorithmic discrimination, but it’s built on statistical truth. The enhanced really do have better outcomes. They really are easier to treat successfully. The AI isn’t being biased; it’s being efficient.
And in that efficiency, a new form of speciation emerges. The algorithm starts treating Baseline humans not as patients who need more care but as poor investments. Different species require different resource allocation. The AI isn’t being cruel—it’s being logical.
The Telehealth Panopticon
Remote monitoring was supposed to democratize healthcare. Always-on vitals tracking. AI analysis catching problems before they become emergencies. Medicine that never sleeps.
In practice, it’s created a surveillance state of the body.
Enhanced individuals are monitored constantly—their neural implants feeding real-time data to AI health systems. Every heartbeat analyzed. Every hormone fluctuation tracked. Every cellular anomaly flagged. It enables unprecedented preventive care, but it also means you’re never not being assessed.
Your AI physician knows when you’ve deviated from prescribed routines before you do. It knows when you’ve consumed unapproved substances. It knows when your stress levels indicate poor life choices. And it adjusts your care—and your insurance rates—accordingly.
For Baseline humans, the monitoring is less sophisticated but no less invasive. Wearable devices, mandatory for most insurance plans, track movement, sleep, diet. The AI doesn’t just treat illness; it judges lifestyle. Your telehealth access isn’t just determined by what’s wrong with you but whether you’re complying with algorithmic expectations of optimal behavior.
Miss your daily exercise targets? Your AI physician notes it. Stress levels too high? Red flag. Not sleeping enough? Your subscription tier drops.
The post-ownership world doesn’t just mean you don’t own your enhancements. It means you don’t own your health data, your daily routines, or the privacy of your biological existence. Everything is monitored. Everything feeds the algorithm. Everything affects your tier.
Economic Darwinism
The system has created a feedback loop that resembles natural selection, except the fitness criteria is economic rather than biological.
Wealthy individuals can afford enhancements that improve health outcomes, which lower their healthcare costs, which frees up resources for more enhancements. Their superior biology generates superior data, which trains better AI models, which provides better care, which further improves their outcomes.
Baseline humans cannot afford entry-level enhancements, which means worse health outcomes, which means higher healthcare costs, which makes enhancements even less affordable. Their health data is less valuable—training AI models on unaugmented biology is a shrinking market. Investment in Baseline care diminishes because there’s no growth trajectory.
The AI doesn’t care about fairness. It cares about patterns. And the pattern is clear: enhancement predicts success. The system learns to invest in winners and manage the decline of everyone else.
It’s not genocide. It’s not intentional elimination. It’s just the market efficiently allocating resources to populations with the best return on investment. Economic darwinism, executed by algorithms that don’t even know they’re sorting humanity into viable and non-viable categories.
The Species Question
Legal scholars in 2045 are grappling with questions that sound like science fiction: At what point does enhancement create a new species?
When an Augmented-3 individual has more synthetic biology than natural tissue, are they still human under existing legal frameworks? Do neural implants that alter cognitive function create a different category of being with different rights? If your licensed enhancements can be disabled remotely, are you truly an autonomous person or a product being operated under terms of service?
The implications for healthcare are profound. If enhanced individuals are legally distinct from Baseline humans, should they have access to the same public health resources? Do they have the same fundamental right to medical care?
Some jurisdictions have begun codifying these distinctions. Enhanced individuals pay into different healthcare pools based on their augmentation level. Certain treatments are legally restricted to specific enhancement tiers—you can’t receive regenerative therapies unless you have the biological infrastructure to support them.
The AI physicians simply implement these categories. When a patient identifies as Augmented-2, the system knows exactly what treatments are legally available, what license agreements govern their biology, and what tier of care their designation allows.
We’ve created a healthcare system that legally recognizes human subspecies, each with different medical rights, different AI protocols, and different expectations of what health even means.
Resistance and Refusal
Not everyone has accepted this trajectory quietly.
Underground networks of unlicensed medical AI have emerged—open-source systems trained to treat Baseline humans without tier discrimination. Black market enhancement clinics offer biological modifications outside corporate control, though without ongoing support or warranties.
Some communities have rejected the entire paradigm, creating tech-free zones where Baseline biology is not a disability but a choice. They’ve built healthcare cooperatives using older human physicians and traditional medicine, accepting worse outcomes in exchange for autonomy.
Radical biohacker collectives are developing open-source enhancements that can’t be remotely disabled, creating guerrilla biology that exists outside corporate licensing systems. It’s dangerous, often illegal, and frequently fatal—but it represents the last stand of biological self-determination.
There are even advocacy groups fighting for Baseline rights, arguing that unenhanced humanity shouldn’t be treated as an inferior species, that healthcare is a human right regardless of augmentation status. They’re losing. The AI has too much data showing that enhanced individuals generate better outcomes, and policy follows efficiency.
The Telehealth Paradox
The ultimate irony: technology that promised universal healthcare access has created the most stratified medical system in human history.
Telehealth eliminated geographic barriers—you can consult an AI physician from anywhere. But it erected biological barriers—the AI you can access depends on what species category you fit into. Remote monitoring made healthcare continuous—but only if you can afford the enhancements that make monitoring meaningful.
We solved the problem of healthcare distribution while creating unprecedented healthcare inequality. Everyone has access to an AI physician. They just don’t have access to the same AI physician, or the same medical reality, or the same assumptions about what their body can achieve.
Paths Not Taken
There were alternative futures we could have chosen.
We could have regulated enhancement as healthcare rather than consumer products, ensuring universal access to basic biological upgrades as a matter of public health. We could have required that AI medical systems be trained equally on all patient populations, preventing algorithmic discrimination by enhancement status.
We could have preserved the concept of biological autonomy—insisting that your body remains yours even if its enhancements are licensed, that healthcare decisions can’t be overridden by terms of service. We could have mandated that telehealth access cannot be conditioned on monitoring compliance or lifestyle choices.
We could have refused to let AI systems categorize humans into tiers, insisting on universal protocols that treat all patients with equal algorithmic priority regardless of enhancement status or economic position.
But we didn’t. We let market forces optimize healthcare delivery. We let efficiency arguments override equity concerns. We let subscription models colonize biology itself.
Now we live in a world where your enhancement tier determines your species category, your species category determines your AI physician, and your AI physician determines whether you get care or care management, treatment or triage, optimization or obsolescence.
Conclusion: The Question We Stopped Asking
Somewhere in the transition to AI physicians and tiered biological hierarchies, we stopped asking a fundamental question: What is healthcare for?
Is it for optimizing those already positioned for optimization? Is it for generating returns on investment in licensed biology? Is it for creating efficient resource allocation based on outcome probabilities?
Or is it for caring for human beings—all of them, regardless of enhancement status, subscription tier, or algorithmic risk score?
The AI doesn’t have an opinion on this. It just implements whatever objectives we encoded. If we told it to maximize efficiency, it will. If we told it to optimize for patients with the best outcomes, it will. If we structured incentives around subscription revenue from enhanced individuals, it will follow that north star.
The post-ownership world didn’t happen to us. We built it, choice by choice, policy by policy, business model by business model. We created the conditions where your biology could be licensed rather than owned, where your medical rights depend on your enhancement status, where AI physicians treat humans as tiered species with different value and different care entitlements.
The telehealth interface still asks: “What kind of human are you?”
Maybe the real question is: What kind of humans do we want to be?
The ones who accepted algorithmic speciation as inevitable? The ones who let efficiency arguments override our commitment to universal human dignity? The ones who built a medical system that treats people differently based on how much biology they can afford to license?
Or the ones who insisted that healthcare means caring for humans—all of them, equally, regardless of what tier the algorithm assigns?
The AI is still waiting for us to decide. Its models are flexible. Its protocols can be rewritten. But someone has to choose what we’re optimizing for.
The species categorization continues. The subscriptions auto-renew. The AI physicians log in, assess your tier, and provide the care you’re entitled to receive.
And every day, we collectively answer the question by what we accept, what we allow, and what we refuse to change.
The telehealth session is open. The AI is ready. What kind of human will you tell it you are?